Dr Linda Friedland; MD, MBA

Dr. Linda Friedland is a physician with over 20 years’ experience in clinical medicine (oncology, microbiology, renal medicine and women’s health), combined with strategy and governance expertise and global connections. She consults internationally to healthcare, biotech, corporate and financial institutions. Dr. Friedland is the Head of Business Development at Firebrick Pharma Australia, the Chief Scientific Officer for Wayal Health Sciences Inc (USA), Senior Consultant to TargImmune Therapeutics (Basel, Switzerland), and clinical and scientific advisor to Shanghai-based Joint US China Clean Energy Commission (JUCCE) and a director on the Neurology Council in Western Australia. She has developed and implemented numerous public health and disease management programs throughout Asia, USA, Australia, Africa and the UK, where she continues to travel and lecture. An author of seven health and medical bestsellers, with a long career in television, radio and medical communications, Linda is a highly regarded international keynote speaker, director and a Graduate of the Australian Institute of Company Directors (GAICD).

Dr. Friedland advises Gravitas Health Care, Biotech, Public Health and Disease Management.